Showing results (311-320 of 350) with videos related to
Sort By:
Pageof 35
Vascular Pharmacology|April 15, 2015
Effect of soluble guanylyl cyclase activator and stimulator therapy on nitroglycerin-induced nitrate tolerance in ratsA Jabs, M Oelze, Y Mikhed, et al.BMC Pharmacology|January 22, 2002
NO-independent regulatory site of direct sGC stimulators like YC-1 and BAY 41-2272E M Becker, C Alonso-Alija, H Apeler, et al.Journal of Hypertension|April 1, 2011
Endothelin-1 overexpression restores diastolic function in eNOS knockout miceNicolas Vignon-Zellweger, Katharina Relle, Elodie Kienlen, et al.International Journal of Cardiology|May 4, 2016
Soluble guanylate cyclase stimulator riociguat and phosphodiesterase 5 inhibitor sildenafil ameliorate pulmonary hypertension due to left heart disease in miceKabita Pradhan, Akylbek Sydykov, Xia Tian, et al.Circulation|April 20, 1999
Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin systemA Warnholtz, G Nickenig, E Schulz, et al.Journal of the American Chemical Society|November 4, 2008
Cationic terminal gallylene complexes by halide abstraction: coordination chemistry of a valence isoelectronic analogue of CO and N2Natalie D Coombs, Dragoslav Vidovic, Joanna K Day, et al.The European Respiratory Journal|June 10, 2010
Therapeutic efficacy of azaindole-1 in experimental pulmonary hypertensionB K Dahal, D Kosanovic, P K Pamarthi, et al.Redox Biology|October 13, 2017
Identification of a soluble guanylate cyclase in RBCs: preserved activity in patients with coronary artery diseaseMiriam M Cortese-Krott, Evanthia Mergia, Christian M Kramer, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|September 22, 2021
Runcaciguat, a novel soluble guanylate cyclase activator, shows renoprotection in hypertensive, diabetic, and metabolic preclinical models of chronic kidney diseaseAgnès Bénardeau, Antje Kahnert, Tibor Schomber, et al.British Journal of Pharmacology|June 28, 2002
NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principleJohannes-Peter Stasch, Peter Schmidt, Cristina Alonso-Alija, et al.Pageof 35